Serum calciprotein particle‐to‐phosphate ratio as a predictor of cardiovascular events in incident hemodialysis patients

Author:

Akiyama Tomoki1ORCID,Iwazu Yoshitaka2,Usui Joichi1,Ebihara Itaru3,Ishizu Takashi45,Kobayashi Masaki6,Maeda Yoshitaka7,Kobayashi Hiroaki8,Yamagata Kunihiro1,Kuro‐o Makoto2,

Affiliation:

1. Department of Nephrology, Faculty of Medicine University of Tsukuba Tsukuba Japan

2. Division of Anti‐aging Medicine, Center for Molecular Medicine Jichi Medical University Shimotsuke Japan

3. Department of Nephrology Mito Saiseikai General Hospital Mito Japan

4. Department of Renal and Dialysis Medicine Tsukuba Central Hospital Ushiku Japan

5. Central Jin Clinic Ryugasaki Japan

6. Department of Nephrology Tokyo Medical University Ibaraki Medical Center Ami Japan

7. Nephrology Division, Department of Internal Medicine JA Toride Medical Center Toride Japan

8. Department of Nephrology Ibaraki Prefectural Central Hospital Kasama Japan

Abstract

AbstractIntroductionRecent studies have identified increased blood calciprotein particle (CPP) levels as risk factors for vascular calcification and cardiovascular events in patients undergoing maintenance hemodialysis. Although positively correlated with serum phosphate levels, serum CPP levels vary considerably among patients with similar serum phosphate levels. We investigated the capacity of the ratio of serum CPP levels to serum phosphate levels (CPP/Pi ratio) to predict cardiovascular events in incident hemodialysis patients compared to the serum calcification propensity test (T50).Methods and ResultsThe association between the CPP/Pi ratio and major adverse cardiac and cerebrovascular events (MACCE) was investigated in 174 incident hemodialysis patients. Multivariate analysis revealed that the CPP/Pi ratio was independently associated with MACCE [hazard ratio 1.60, 95% confidence interval (1.15–2.23), p = 0.006] but serum T50 levels were not.ConclusionsThe CPP/Pi ratio is a useful, novel biomarker for predicting the risk of cardiovascular events in patients undergoing incident hemodialysis.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3